“…472). Recent candidate gene association studies (Baker et al, 2009;Bergen et al, 2009;Bierut et al, 2008;Breitling et al, 2009a, b;Chen et al, 2008Chen et al, , 2009Etter et al, 2009;Freathy et al, 2009;Greenbaum et al, 2006;Hoft et al, 2009;Keskitalo et al, 2009;Le Marchand et al, 2008;Li et al, , 2009Perkins et al, 2008aPerkins et al, , b, 2009Philibert et al, 2009;Rigbi et al, 2008;Saccone et al, 2009a, b;Sherva et al, 2008;Spitz et al, 2008;Stevens et al, 2008;Wang et al, 2009;Weiss et al, 2008), and genome-wide association scans (GWASs) (Drgon et al, 2009a, b;Liu et al, 2010Liu et al, , 2009TAG, 2010;Thorgeirsson et al, 2008Thorgeirsson et al, , 2010, with many published candidate gene and GWAS studies through 2009 referenced by Wang and Li (2010), have searched for, and, at varying levels of significance, identified, common variants associated with measures of response to tobacco, tobacco consumption, nicotine dependence, nicotine metabolism, or smoking cessation. However, most of the attributable fraction assumed to be due to heredity cannot be explained by these common single-nucleotide polymorphisms (SNPs), suggesting that rare variants in candidate genes, ie, those with minor allele frequencies (MAFs) substantially o5%, may also contribute to complex disease (Bodmer and Bonilla, 2008;Frazer et al, 2009;Schork et al, 2009).…”